Submit Content
Get the latest delivered to your inbox
Privacy Policy

Teva Pharmaceuticals

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com.

    Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy Image

    POSTED 

    01-12-21

    Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

    Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has announced long-term environmental sustainability commitments and targets to provide direction and drive action in this area.
    International Childhood Cancer Day Announcement: Global Hope, Teva and Direct Relief Partner to  Bring Medicines to Help Improve the Lives of Children With Cancer in Africa Image

    POSTED 

    02-14-20

    International Childhood Cancer Day Announcement: Global Hope, Teva and Direct Relief Partner to Bring Medicines to Help Improve the Lives of Children With Cancer in Africa

    Global HOPE (Hematology-Oncology Pediatric Excellence), a program of Texas Children’s Hospital, Teva Pharmaceutical Industries Ltd. and Direct Relief announced today a donation partnership that will provide access to medications in sub-Saharan Africa—where an overwhelming majority of pediatric ca...

    New Initiative Creates Scalable Solutions to Improve Care of Patients With Multiple Chronic Conditions Image

    POSTED 

    09-18-17

    New Initiative Creates Scalable Solutions to Improve Care of Patients With Multiple Chronic Conditions

    Today, two leading private sector groups announced a partnership to create scalable solutions to improve patient and health system care for Multiple Chronic Conditions.

    The initiative was announced to an audience of public health leaders at the World Economic Forum’s (WEF) Sustainable Deve...

    Teva Continues to Advance Care for Society’s Health and Wellbeing; 2016 Social Impact Report Released Image

    POSTED 

    09-14-17

    Teva Continues to Advance Care for Society’s Health and Wellbeing; 2016 Social Impact Report Released

    In 2016, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) engaged more than 300,000 people in 35 countries in programs aimed to help and empower patients as they deal with their illnesses.

    These patient support programs are among the outcomes of broader efforts...

    Teva Announces 2017-18 U.S. Community Partner Organizations Image

    POSTED 

    01-26-17

    Teva Announces 2017-18 U.S. Community Partner Organizations

    Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the U.S. organizations selected as part of Teva’s 2017-18 Community Partnership Program. Now in its fourth year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that s...

    Teva Pharmaceuticals Accepting Applications for the 2017-18 Community Partnership Program through October 21, 2016 Image

    POSTED 

    09-19-16

    Teva Pharmaceuticals Accepting Applications for the 2017-18 Community Partnership Program through October 21, 2016

    Teva Pharmaceuticals is now accepting entries for the 2017-18 Teva Community Partnership Program. Now in its third year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that support patients and their caregivers and...

    Teva Announces 2016 U.S. Community Partner Organizations Image

    POSTED 

    01-28-16

    Teva Announces 2016 U.S. Community Partner Organizations

    Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the U.S. organizations selected as part of Teva’s 2016 Community Partnership Program. Now in its fifth year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that suppo...

    Teva Pharmaceuticals Accepting Applications for the 2016 Community Partnership Program Through October 1, 2015 Image

    POSTED 

    09-03-15

    Teva Pharmaceuticals Accepting Applications for the 2016 Community Partnership Program Through October 1, 2015

    Teva Pharmaceuticals is now accepting entries for the 2016 Teva Community Partnership Program. Now in its fifth year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that support patients and their caregivers in geo...

    Teva Pharmaceuticals and the Philadelphia Eagles Award Four Grants to Greater Philadelphia Area Service Organizations Image

    POSTED 

    10-27-10

    Teva Pharmaceuticals and the Philadelphia Eagles Award Four Grants to Greater Philadelphia Area Service Organizations

    /PRNewswire/ - Teva Pharmaceuticals, in collaboration with the Philadelphia Eagles, today announced that it has awarded four grants totaling $125,000 to Philabundance, Students Run Philly Style, Twilight Wish Foundation and The Miracle League of Northampton Township, as part...

    Teva Pharmaceuticals Logo

    Teva Pharmaceuticals

    Teva Pharmaceuticals

    Join today and get the latest delivered to your inbox